In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
Germany’s Merck KGaA today announced that next year Dr Stefan Oschmann, chairman of the firm’s executive board of Merck, will hand over the position to Dr Belén Garijo, who will also become chief executive on May 1, 2021. 28 September 2020
Pharmaceutical
French drugmaker Ipsen today announced the appointment of Philippe Lopes-Fernandes as executive vice president, chief business officer, effective October 1, 2020. 25 September 2020
Biotechnology
California, USA-based Nutcracker Therapeutics, a company developing and producing mRNA therapeutics, today announced not only a financing deal but also a new senior executive. 23 September 2020
Pharmaceutical
Privately-held Danish medical dermatology specialist LEO Pharma today said that Becki Morison will join the company, effective October 1 in the position of executive vice president, global therapeutics and value strategy. 23 September 2020
Biotechnology
Shares in Legend Biotech fell by nearly 16% in the first four hours of trading on Monday. 21 September 2020
Biotechnology
Privately-held Finnish company Forendo Pharma has announced that Cristina Csimma has been appointed chairwoman of the board of directors. 16 September 2020
Biotechnology
Swedish biotech Immunicum has appointed Dr Sven Rohmann as chief executive, effective immediately. 28 August 2020
Generics
Israel’s largest drugmaker and generics giant Teva Pharmaceutical beat analysts’ profit forecasts for the second quarter, with a slightly smaller dip in profits at $1.8 billion. 5 August 2020
Pharmaceutical
While revenues declined 2% to $5.4 billion, USA-based drugmaker Eli Lilly beat profit forecasts for the second quarter of 2020, the firm announced on Thursday. 30 July 2020
Pharmaceutical
Growing revenues and profitability in step with pipeline development, British drugmaker AstraZeneca posted an upbeat second quarter results statement on Thursday, with a strong focus on efforts to combat the novel coronavirus. 30 July 2020
Pharmaceutical
Despite second quarter sales being undercut by the coronavirus pandemic, French drugs and vaccines specialist Sanofi has raised its projection for the year, spurred by cost cutting measures and the sale of its stake in Regeneron Pharmaceuticals. 29 July 2020
Pharmaceutical
LEO Pharma’s UK and Ireland business has appointed a new medical affairs lead, Amit Aggarwal, formerly director of UK medical affairs at Bayer. 23 July 2020
Pharmaceutical
Following the appointment of Haseeb Ahmad to the role of global head of value and access and commercial development, Chinmay Bhatt has taken on the position of managing director UK, Ireland & Nordics for Novartis. 21 July 2020
Biotechnology
US clinical-stage biopharma company Scholar Rock today announced the appointment of Tony Kingsley as president and chief executive, effective August 1, 2020. 14 July 2020
Pharmaceutical
Denmark-headquartered Abacus Medicine is set to acquire Dutch pharmaceutical wholesaler Pluripharm Group. 13 July 2020
Biotechnology
US clinical-stage biotech Cardurion Pharmaceuticals has appointed Dr Chris Morabito as chief medical officer (CMO). 9 July 2020
Biotechnology
Belgian biotech BCI Pharma has appointed Didier Malherbe as chairman of the board of directors. 6 July 2020
Pharmaceutical
Privately-held Danish medical dermatology specialist LEO Pharma today announced that Dr Monica Shaw and Nathalie Joannes will join the executive leadership team adding seasoned experience and international profile to the company. 1 July 2020
Pharmaceutical
UK-based Indivior’s shares rose nearly 4% to 79.05 pence in early trading, after it announced that, effective today, Mark Crossley is appointed chief executive. However, the stock was down 1% at 78.00 pence by late morning. 29 June 2020
Pharmaceutical
The European Medicines Agency (EMA) Management Board has announced its nomination for the new executive director of the Agency to replace the outgoing Professor Guido Rasi, who is due to end his term in the position that he has held since 2011 (minus an off-stint due to a controversy over the selection procedure). 25 June 2020
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze